PHARMAQ
Non-medicinal delousing approaches cause damage to salmon gill tissue
New research shows that thermal and mechanical delousing techniques used in Atlantic salmon aquaculture can cause damage to gill tissue, though the health impacts of this on farmed fish remain unknown.
Managing high-tech vaccination on Canada’s salmon farms
Demand for vaccination is ever-growing in the Canadian salmon industry, and the country’s producers have made a big shift toward mechanized approaches in getting the job done.
New research on deltamethrin resistance could pave way for optimized sea lice treatment
New research on deltamethrin resistance in sea lice could help improve the effectiveness and reduce the costs of treating the global salmon industry’s “billion-dollar problem.”
Safety and welfare concerns drive shift to licensed anesthetic in Mediterranean aquaculture
Improving standards on Mediterranean fish farms is driving interest in Tricaine PHARMAQ — the only authorized fish anesthetic product.
Vaccines boost Greece’s seabass and seabream aquaculture — but challenges remain
Aquaculture in Greece has endured some ups and downs since its establishment in the 1980s, from the Greek financial crisis to the Covid-19 pandemic.
Managing pandemic pressures in aquaculture’s diagnostic labs
The Covid-19 pandemic has, to some extent, made epidemiologists of all of us. But for microbiologists focused on pathogens that don’t affect humans, it has created some new challenges.
Fish vaccination a key part of future success for world’s largest pangasius producer
The key to the continued growth of the pangasius industry is being more innovative in solving its main fish health, quality and sustainability challenges.
Vaccines provide Brazil’s fish farmers with a platform for sustainable growth
An interview with Danielle Zanerato Damasceno, Technical and Commercial Manager, PHARMAQ Brazil
- « Previous
- 1
- 2
- 3
- 4
- Next »
